Japanese Yen pares recent gains due to wide US-Japan interest rate differential
USD/JPY pares its daily gains, still remaining in the positive territory and trading around 160.10 during the Asian hours on Monday. The Japanese Yen (JPY) has found a solid foothold in the wake of the geopolitical breakthrough. The reopening of the Strait of Hormuz caused oil prices to plunge to a two-month low, significantly easing inflationary pressures and reducing crippling import costs for energy-dependent economies like Japan.
However, the JPY's upside remains capped, as the substantial interest rate gap between Japan and the United States (US) continues to provide structural support to the USD/JPY pair. The JPY may receive further domestic support as traders price in a potential Bank of Japan (BoJ) interest rate hike on Tuesday to contain local inflation.
The USD/JPY pair depreciated as the US Dollar (USD) declined following reports that the United States (US) and Iran reached a deal to end their conflict, easing concerns about inflation and higher interest rates.
Following a landmark peace agreement between the United States (US) and Iran, market expectations for monetary policy have shifted dramatically. The CME FedWatch tool now indicates a nearly 47% probability that the Federal Reserve (Fed) will hold interest rates unchanged in December, a sharp increase from the 28% priced in just last week.
The deal, announced on Sunday by Washington and Tehran, is set to take effect this Friday. As part of the agreement, US President Donald Trump stated that the United States will lift its naval blockade on Iranian ports, allowing the critical Strait of Hormuz to reopen. In a coordinated response, the United Kingdom, France, Germany, and Italy announced they are prepared to lift sanctions on Iran following steps taken regarding its nuclear program.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
